V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212455 | 20079084 | null | null | Palliative (P) | 2018-09-12 | 2018-10-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100154646 |
| 20212456 | 20079085 | 0 | 0 | Curative (C) | 2016-07-18 | 2016-07-27 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100423041 |
| 20212457 | 20079086 | 0 | 0 | Neo-adjuvant (N) | 2016-09-15 | 2016-09-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101095116 |
| 20212458 | 20079087 | 0 | 0 | Curative (C) | 2016-10-16 | 2016-11-07 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100078367 |
| 20212459 | 20079088 | 0 | 0 | Neo-adjuvant (N) | 2018-07-23 | 2018-07-30 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100723889 |
| 20212460 | 20079089 | 1.54 | 71 | Palliative (P) | 2012-03-13 | 2016-12-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100839306 |
| 20212462 | 20079090 | 1.57 | 57.8 | Palliative (P) | 2019-01-29 | 2019-02-08 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101488151 |
| 20212463 | 20079091 | 1.75 | 82.15 | Palliative (P) | 2016-05-29 | 2016-06-06 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101835708 |
| 20212464 | 20079092 | 1.57 | 63 | Palliative (P) | 2017-11-01 | 2017-11-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101365642 |
| 20212465 | 20079093 | 1.6 | 59.4 | Palliative (P) | 2018-09-08 | 2018-09-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100501139 |
| 20212466 | 20079094 | 1.64 | 81 | Palliative (P) | 2017-08-09 | 2017-08-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100611337 |
| 20212467 | 20079095 | 1.61 | 52 | Neo-adjuvant (N) | 2019-04-05 | 2019-04-11 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101797961 |
| 20212468 | 20079096 | 1.69 | 67.55 | Neo-adjuvant (N) | 2018-06-18 | 2018-06-19 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101748365 |
| 20212469 | 20079097 | 1.69 | 86.4 | Neo-adjuvant (N) | 2018-07-01 | 2018-07-08 | Capecitabine (21days) + Carboplatin | N | Y | CAPECITABINE + CARBOPLATIN | 100915876 |
| 20212470 | 20079098 | null | 0 | Palliative (P) | 2019-03-24 | 2019-04-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100692000 |
| 20212471 | 20079099 | 1.7 | null | Curative (C) | 2017-08-26 | 2017-08-30 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101049656 |
| 20212472 | 20079100 | 0 | 0 | null | null | 2018-04-29 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100204589 |
| 20212473 | 20079101 | 1.67 | 97.9 | null | 2018-08-14 | 2018-08-29 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100508303 |
| 20212475 | 20079102 | 0 | 0 | null | 2016-02-17 | 2016-02-27 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101599999 |
| 20212477 | 20079103 | 1.57 | 78 | Palliative (P) | 2017-04-14 | 2017-04-14 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101616829 |
| 20212478 | 20079104 | 0 | 0 | Palliative (P) | 2017-07-12 | 2017-07-17 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100498306 |
| 20212479 | 20079105 | 1.91 | 54.7 | Neo-adjuvant (N) | 2018-10-20 | 2018-10-20 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101552030 |
| 20212480 | 20079106 | 1.73 | 76.6 | Palliative (P) | 2019-01-13 | 2019-02-12 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100603743 |
| 20212481 | 20079107 | 1.6 | 92.3 | Palliative (P) | 2017-05-05 | 2017-05-05 | CAPECITABINE + CARBOPLATIN | 02 | null | CISPLATIN + FLUOROURACIL | 101657011 |
| 20212482 | 20079108 | 1.62 | 69.5 | null | 2019-06-19 | 2019-06-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101059947 |
| 20212484 | 20079109 | 1.8 | 95.3 | Curative (C) | 2017-10-12 | 2017-10-12 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100650782 |
| 20212485 | 20079110 | null | 132.9 | null | 2016-10-16 | 2016-10-17 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101625907 |
| 20212486 | 20079111 | null | 100 | Palliative (P) | 2019-05-25 | 2019-06-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101194853 |
| 20212487 | 20079112 | 1.68 | 78 | Curative (C) | 2019-03-29 | 2019-03-29 | CISPLATIN + FLUOROURACIL | null | Y | CISPLATIN + FLUOROURACIL | 101144853 |
| 20212488 | 20079113 | 1.69 | 45.6 | null | 2018-09-15 | 2018-09-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100362655 |
| 20212489 | 20079114 | 1.63 | 103 | Neo-adjuvant (N) | 2019-01-14 | 2019-01-20 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101432382 |
| 20212491 | 20079115 | 0 | 0 | Adjuvant (A) | null | 2017-11-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101748567 |
| 20212492 | 20079116 | 1.7 | 78.7 | Palliative (P) | 2019-04-21 | 2019-04-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101584842 |
| 20212493 | 20079117 | null | 51.5 | null | 2017-02-06 | 2017-02-08 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100027547 |
| 20212495 | 20079118 | 1.59 | 65.8 | Neo-adjuvant (N) | null | 2017-10-15 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100667426 |
| 20212496 | 20079119 | 0 | 0 | 03 | 2019-06-10 | 2019-06-10 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100875894 |
| 20212498 | 20079120 | 1.76 | 100 | Palliative (P) | 2016-10-11 | 2016-10-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101688803 |
| 20212499 | 20079121 | 1.74 | 70.9 | null | 2019-09-17 | 2019-09-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100633935 |
| 20212501 | 20079122 | 1.52 | 99.6 | Disease modification (D) | 2016-12-23 | 2017-01-06 | CAPECITABINE + CARBOPLATIN | 2 | N | CAPECITABINE + CARBOPLATIN | 101162966 |
| 20212503 | 20079123 | 0 | 0 | Neo-adjuvant (N) | 2018-01-30 | 2018-02-13 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100563257 |
| 20212504 | 20079124 | 1.85 | 87 | Curative (C) | 2018-06-13 | 2018-06-27 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101691552 |
| 20212505 | 20079125 | null | 70.7 | Palliative (P) | 2018-02-09 | 2018-02-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100563843 |
| 20212508 | 20079126 | 1.77 | 88.5 | Palliative (P) | 2017-03-29 | 2017-04-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100644354 |
| 20212509 | 20079127 | null | 58 | Palliative (P) | 2021-09-14 | 2021-10-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100536684 |
| 20212510 | 20079128 | 1.68 | 70 | Curative (C) | 2019-03-15 | 2019-03-22 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100454608 |
| 20212512 | 20079129 | 1.58 | 91.6 | Neo-adjuvant (N) | 2019-12-19 | 2019-12-19 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101638396 |
| 20212513 | 20079130 | 1.58 | 51.7 | Neo-adjuvant (N) | 2018-10-25 | 2018-10-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100550620 |
| 20212514 | 20079131 | 1.75 | 87 | Neo-adjuvant (N) | 2018-10-13 | 2018-11-11 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101655062 |
| 20212515 | 20079132 | 0 | 0 | Curative (C) | 2016-11-24 | 2017-01-03 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100394523 |
| 20212516 | 20079133 | 1.61 | 86.5 | null | 2019-08-21 | 2019-08-26 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100294510 |